The Houston-based Empower Pharmacy is seeking to dismiss a lawsuit that targets its ability to sell popular diabetes and ...

Houston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling "knockoff" versions of its weight loss and ...

Eli Lilly ( LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following ...

U.S. drugmaker Eli Lilly said on Monday it will offer the higher dose versions of its popular weight-loss drug Zepbound on ...

Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic jolt that could accelerate the city’s ambitions to become a national ...

A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed investment into a new facility. Eli Lilly applied for a tax abatement under ...

HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...

Eli Lilly was already in negotiations “with several states” at the time of that announcement and invited additional interest. Despite the tax incentive application, the Houston project isn't ...

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...